Hyperthermia-induced upregulation of vascular endothelial growth factor in retinal pigment epithelial cells is regulated by mitogen-activated protein kinases

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 252, Issue 11, 2014, Pages 1737-1745

  Faby, Hendrik ^a   Hillenkamp, Jost ^a   Roider, Johann ^a   Klettner, Alexa ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Hyperthermia; MAPK; RPE; TRPV; VEGF

Indexed keywords

ENZYME INHIBITOR; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

CELL LINE; CELL SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HYPERTHERMIC THERAPY; METABOLISM; PHOSPHORYLATION; PIGMENT EPITHELIUM; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERTHERMIA, INDUCED; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RETINAL PIGMENT EPITHELIUM; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84928762155     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-014-2750-z     Document Type: Article

References (69)

1. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845–881
2. Ambati J, Fowler BJ (2012) Mechanisms of age-related macular degeneration. Neuron 75:26–39
3. Chen H, Liu B, Lukas TJ, Neufeld AH (2008) The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS ONE 3:e2339
4. McLeod DS, Grebe R, Bhutto I, Merges C, Baba T, Lutty GA (2009) Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 50:4982–4991
5. Bhutto I, Lutty G (2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. Mol Asp Med 33:295–317
6. Klettner A (2013) Physiological Functions of VEGF in the Retina and Its Possible Implications of Prolonged Anti-VEGF Therapy. In: Parker ML(edt) Vascular Endothelial Growth Factor: Biology, Regulation and Clinical Significance. Nova Biomedical pp117-136.
7. Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122:4213–4217
8. Grunwald JE, Daniel E, Huang J, Ying GS, Maguire MG, Toth CA, Jaffe GJ, Fine SL, Blodi B6, Klein ML, Martin AA, Hagstrom SA, Martin DF; CATT Research Group (2014) Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology 121:150–156
9. Witmer AN, Vrensen GF, Van Noorden CJ (2003) Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1–29
10. Blaauwegeers HGT, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, Partanen TA, Alitalo K, Kroon ME, Kijlstra A, van Hinsbergh VW, Schlingemann RO (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris evidence for a trophic paracrine relation. Am J Pathol 155:421–428
11. Klettner A, Roider J (2012) Mechanisms of Pathological VEGF Production in the Retina and Modification with VEGF-Antagonists. In: Stratton R, Hauswirth W, Gardner T (eds) Oxidative Stress in Applied Basic Research and Clinical Practise: Studies on Retinal and Choroidal Disorders. Humana Press, New York, pp 277–307
12. Klettner A, Koinzer S, Meyer T, Roider J (2013) Toll-like receptor 3 activation in retinal pigment epithelium cells- Mitogen-activated protein kinase pathways of cell death and vascular endothelial growth factor secretion. Acta Ophthalmol 91:e211–e218
13. Kannan R, Zhang N, Sreekumar P, Spee C, Rodriguez A, Barron E, Hinton DR (2006) Stimulation of apical and basolateral vascular endothelial growth factor-A and vascular endothelial growth factor-C secretion by oxidative stress in polarized retinal pigment epithelial cells. Mol Vis 12:1649–1659
14. Coassin M, Duncan KG, Bailey KR, Singh A, Schwartz DM (2010) Hypothermia reduces secretion of vascular endothelial growth factor by cultured retinal pigment epithelial cells. Br J Ophthalmol 94:1678–1683
15. Cordeiro S, Seyler S, Stindl J, Milenkovic VM, Strauss O (2010) Heat-sensitive TRPV channels in retinal pigment epithelial cells: regulation of VEGF-A secretion. Invest Ophthalmol Vis Sci 51:6001–6008
16. Parver LM, Auker C, Carpenter DO (1980) Choroidal blood flow as a heat dissipating mechanism in the macula. Am J Ophthalmol 89:641–646
17. Nickla DL, Wallman J (2010) The multifunctional choroid. Prog Retin Eye Res 29:144–168
18. Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker JA, Dunaief JL (2008) Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 49:358–363
19. Boltz A, Luksch A, Wimpissinger B, Maar N, Weigert G, Frantal S, Brannath W, Garhöfer G, Ergun E, Stur M, Schmetterer L (2010) Choriodal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci 51:4220–4225
20. Journee-de Korver JG, Oosterhuis JA, van Best JA, Fakkel J (1991) Xenon arch photocoagulator used for transpupillary hyperthermia. Doc Ophthalmol 78:183–187
21. Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC (1995) Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 113:315–321
22. Nowak MS, Jurowski P, Grzybowski A, Gos R, Pastuszka M, Kapica A, Smigielski J (2012) A prospective study on different methods for the treatment of choroidal neovascularization. The efficacy of verteporfin photodynamic therapy, intravitreal bevacizumab and transpupillary thermotherapy in patients with neovascular age-related macular degeneration. Med Sci Monit 18:CR374–CR380
23. Söderberg AC, Algvere PV, Hengstler JC, Söderberg P, Seregard S, Kvanta A (2012) Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study. Br J Ophthalmol 96:714–718
24. Francis JH, Abramson DH, Brodie SE, Marr BP (2013) Indocyanine green enhanced transpupillary thermotherapy in combination with ophthalmic artery chemosurgery for retinoblastoma. Br J Ophthalmol 97:164–168
25. Caminal JM, Mejia-Castillo KA, Arias L, Catala J, Rubio M, Garcia P, Pujol O, Arruga J (2013) Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions. Retina 33:194–199
26. Sharma T, Krishnan T, Gopal L, Nagpal A, Khetan V, Rishi P (2011) Transpupillary thermotherapy for circumscribed choroidal hemangioma: clinical profile and treatment outcome. Ophthalmic Surg Lasers Imaging 42:360–368
27. Rougier MB, Francois L, Fourmaux E, Isber R, Colin J, Korobelnik JF (2005) Complications and lack of benefit after transpupillary thermotherapy for occult choroidal neovascularization: 1-year results. Retina 25:784–788
28. Yarovoy AA, Magaramov DA, Bulgakova ES (2010) Which choroidal melanoma should be treated with primary transpupillary thermotherapy? Our experience from 78 patients. Eur J Ophthalmol 20:186–193
29. Parrozzani R, Boccassini B, De Belvis V, Radin PR, Midena E (2009) Long term outcome of transpupillary thermotherapy as primary treatment of selected choroidal melanoma. Acta Ophthalmol 87:789–792
30. Finger PT, Lipka AC, Lipkowitz J, Jofe M, McCormick SA (2000) Failure of transpupillary thermotherapy (TTT) for choroidal melanoma: two cases with histopathological correlation. Br J Ophthalmol 84:1075–1082
31. Klettner A, Westhues D, Lassen J, Bartsch S, Roider J (2013) Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor kappaB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway. Mol Vis 19:281–291
32. Berra E, Pagès G, Pouysségur J (2000) MAP kinases and hypoxia in the control of VEGF expression. Cancer Metastasis Rev 19:139–145
33. Milanini-Mongiat J, Pouysségur J (2002) Identification of two p42/p44 mitogen activated kinases phosphorylation sites on Sp1: Their implication on vascular endothelial growth factor gene transcription. J Biol Chem. doi:10.1074/jbc.M201753200
34. Pagès G, Berra E, Milanini J, Levy AP, Pouysségur J (2000) Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 275:26484–26491
35. Kawano Y, Utsunomiya-Kai Y, Kai K, Miyakawa I, Ohshiro T, Narahara H (2012) The production of VEGF involving MAP kinase activation by low level laser therapy in human granulosa cells. Laser Ther 21:269–274
36. Raidl M, Sibbing B, Strauch J, Müller K, Nemat A, Schneider PM, Hag H, Erdmann E, Koch A (2007) Impaired TNFalpha-induced VEGF expression in human airway smooth muscle cells from smokers with COPD: role of MAPkinases and histone acetylation–effect of dexamethasone. Cell Biochem Biophys 49:98–110
37. Tanaka T, Kanai H, Sekiguchi K, Aihara Y, Yokoyama T, Arai M, Kanda T, Nagai R, Kurabayashi M (2000) Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. J Mol Cell Cardiol 32:1955–1967
38. Bian ZM, Elner SG, Elner VM (2007) Thrombin-induced VEGF expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 48:2738–2746
39. Weng CY, Kothary PC, Verkade AJ, Reed DM, Del Monte MA (2009) MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE). Curr Eye Res 34:867–876
40. Klettner A, Roider J (2009) Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases. Graefes Arch Clin Exp Ophthalmol 247:1487–1492
41. Kunchithapautham K, Rohrer B (2011) Sublytic membrane-attack-complex (MAC) activation alters regulated rather than constitutive vascular endothelial growth factor (VEGF) secretion in retinal pigment epithelium monolayers. J Biol Chem 286:23717–23724
42. Klettner A, Koinzer S, Waetzig V, Herdegen T, Roider J (2010) Deferoxamine mesylate is toxic for retinal pigment epithelium cells, and its toxicity is mediated by p38. Cutan Ocul Toxicol 29:122–129
43. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp Eye Res 62:155–169
44. Zeng F, Zhang M, Xu Y, Xu H (2013) ARMS2 interference leads to decrease of proinflammatory mediators. Graefes Arch Clin Exp Ophthalmol 251:2539–2544
45. Yokoyama K, Kimoto K, Itoh Y, Nakatsuka K, Matsuo N, Yoshioka H, Kubota T (2012) The PI3K/Akt pathway mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol 250:15–23
46. Ahmado A, Carr AJ, Vugler AA, Semo M, Gias C, Lawrence JM, Chen LL, Chen FK, Turowski P, da Cruz L, Coffey PJ (2011) Induction of differentiation by pyruvate and DMEM in the human retinal pigment epithelium cell line ARPE-19. Invest Ophthalmol Vis Sci 52:7148–7159
47. Alge CS, Hauck SM, Priglinger SG, Kampik A, Ueffing M (2006) Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival. J Proteome Res 5:862–878
48. Cai H, Del Priore LV (2006) Gene expression profile of cultured adult compared to immortalized human RPE. Mol Vis 12:1–14
49. Tian J, Ishibashi K, Honda S, Boylan SA, Hjelmeland LM, Handa JT (2005) The expression of native and cultured human retinal pigment epithelial cells grown in different culture conditions. Br J Ophthalmol 89:1510–1517
50. Ford KM, Saint-Geniez M, Walshe T, Zahr A, D'Amore PA (2011) Expression and role of VEGF in the adult retinal pigment epithelium. Invest Ophthalmol Vis Sci 52:9478–9487
51. Bergmann M, Holz F, Kopitz J (2011) Lysosomal stress and lipid peroxidation products induce VEGF-121 and VEGF-165 expression in ARPE-19 cells. Graefes Arch Clin Exp Ophthalmol 249:1477–1483
52. Bai L, Zhu X, Ma T, Wang J, Wang F, Zhang S (2013) The p38 MAPK NF-κB pathway, not the ERK pathway, is involved in exogenous HIV-1 Tat-induced apoptotic cell death in retinal pigment epithelial cells. Int J Biochem Cell Biol 45:1794–1801
53. Watanabe K, Zhang XY, Kitagawa K, Yunoki T, Hayashi A (2009) The effect of clonidine on VEGF expression in human retinal pigment epithelial cells (ARPE-19). Graefes Arch Clin Exp Ophthalmol 247:207–213
54. Chen Y, Kijlstra A, Chen Y, Yang P (2011) IL-17A stimulates the production of inflammatory mediators via Erk1/2, p38 MAPK, PI3K/Akt, and NF-κB pathways in ARPE-19 cells. Mol Vis 17:3072–3077
55. Sekiyama E, Saint-Geniez M, Yoneda K, Hisatomi T, Nakao S, Walshe TE, Maruyama K, Hafezi-Moghadam A, Miller JW, Kinoshita S, D'Amore PA (2011) Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity. FASEB J 26:567–575
56. Yin L, Wu X, Gong Y, Shi Y, Qiu Y, Zhang H, Liu X, Gu Q (2011) OX-LDL up-regulates the vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in human retinal pigment epithelial cells. Curr Eye Res 36:379–385
57. Vay L, Gu C, McNaughton PA (2012) The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol 165:787–801
58. Saint-Geniez M, Maharaj ASR, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D'Amore PA (2008) Endogenous VEGF is required for visual function: Evidence for a survival role on Müller cells and photoreceptors. PLoS One 3:e3554
59. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado A, D'Amore P (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 106:18751–18756
60. Byeon SH, Lee SC, Choi SH, Lee HK, Lee JH, Chu YK, Kwon OW (2010) Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGFR-2/PI3K/Akt pathway. Invest Ophthalmol Vis Sci 51:1190–1197
61. El-Remessy AB, Bartoli M, Platt DH, Fulton D, Caldwell RB (2005) Oxidative stress inactivates VEGF survival signaling in retinal endothelial cells via PI 3-kinase tyrosine nitration. J Cell Sci 118:243–252
62. Kilic Ü, Kilic E, Järve A, Guo Z, Spudich A, Bieber K, Barzena U, Bassetti CL, Marti HH, Hermann DM (2006) Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK1/2 and Akt pathways. J Neurosci 26:12439–12446
63. Miller DW, Joussen AM, Holz FG (2003) Die molekularen Mechanismen der neovaskulären AMD. Ophthalmologe 100:92–96
64. Scholl S, Kirchhof J, Augustin AJ (2010) Pathophysiology of macular edema. Ophthalmologica 224:8–15
65. Tolentino MJ (2009) Current molecular understanding and future treatment strategies for pathological ocular neovascularization. Curr Mol Med 9:973–981
66. Yang H, Jager MJ, Grossniklaus HE (2010) Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci 51:2835–2842
67. Stoffelns BM (2002) Transpupillary thermotherapy (TTT) for malignant choroidal melanoma. Acta Ophthalmol 80:25–31
68. Stoffelns BM (2006) Morphologische und funktionelle Ergebnisse nach transpupillarer Thermotherapie (TTT) maligner Aderhautmelanome. Klin Monatsbl Augenheilkd 223:74–80
69. Schöpfer K, Stoffelns B (2010) Development of choroidal neovascularisation following transpupillary thermotherapy (TTT) for a small malignant melanoma of the choroid at the posterior pole – a case report. Med Laser Appl 25:223–228